Participation rate of the target population in colorectal cancer screening – results from the evaluation of the National Colorectal Cancer Screening Program in the Czech Republic
Endoscopy · 01.04.2024 · 56 (S 02 S 02) · S476-S477
DOI: 10.1055/s-0044-1783909 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endoscopy, erschienen am 01.04.2024. Verfasst von T. Grega und 7 weiteren Autor:innen.
Abstract (Originalsprache)
Aims
The National Colorectal Cancer (CRC) Screening Program was launched in the Czech Republic in 2000 as an opportunistic screening program. In 2014, this program was transformed into a population-based program by introducing an address invitation of the target population. This led to a significant increase in the participation rate of the target population in CRC screening. Due to the covid pandemic, overall participation significantly dropped during years 2020 and 2021. The main aim of the study was to evaluate the level of participation of the target population in the CRC screening program. Other objectives included evaluating the effectiveness of screening tests (FOBT, screening colonoscopy, FOBT-positive colonoscopy).
Methods
The evaluation used the registries of the National Health Information System, the Registry of Preventive Colonoscopies, and data on population demographics managed by the Czech Statistical Office. The analysis was carried out on available data up to 2022. Basic indicators were calculated in accordance with international recommendations, which were adapted for the Czech environment.
Results
Coverage of the target population with CRC screening tests in the Czech Republic (4.1 million people over 50 years of age) varied from 43.0% (year 2012) increasing to the maximum 53.1% (year 2016) and decreasing to 47.8% (year 2022). By the end of 2022, FOBTs had been performed in 1,490,661 individuals (36%), screening colonoscopies in 109,200 individuals (2.6%), diagnostic colonoscopies in 283,462 patients (6.8%), and diagnostic FOBTs in 97,505 (2 .4%) individuals. The positivity of the screening FOBT reached 10% (increase from 7% in 2019), which led to an increase in the waiting time for a colonoscopy to an average of 70 days. The overall compliance for follow-up FOBT positive colonoscopy was 60-70%. The proportion of detected colorectal adenomas and carcinomas in the screening colonoscopy was 31% and 1%, respectively, and in FOBT positive colonoscopy 45% and 3%, respectively.
Conclusions
The evaluated indicators show that despite the positive impact of the screening program on the participation rate, it still has its opportunities for improvement, and therefore it is essential to continue its monitoring to improve the quality of the whole program. Supported by the educational projects MO1012 and Cooperatio. Publication History Article published online: 15 April 2024 © 2024. European Society of Gastrointestinal Endoscopy. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
Zitieren
APA
Grega, T., Ngo, O., Ambrozova, M., Hejcmanova, K., Chloupkova, R., Majek, O., Zavoral, M., & Suchanek, S. (2024). Participation rate of the target population in colorectal cancer screening – results from the evaluation of the National Colorectal Cancer Screening Program in the Czech Republic. Endoscopy, 56(S 02 S 02), S476-S477. https://doi.org/10.1055/s-0044-1783909
Vancouver
Grega T, Ngo O, Ambrozova M, Hejcmanova K, Chloupkova R, Majek O, et al. Participation rate of the target population in colorectal cancer screening – results from the evaluation of the National Colorectal Cancer Screening Program in the Czech Republic. Endoscopy. 2024;56(S 02 S 02):S476-S477. doi:10.1055/s-0044-1783909
BibTeX
@article{Grega2024,
author = {Grega, T. and Ngo, O. and Ambrozova, M. and Hejcmanova, K. and Chloupkova, R. and Majek, O. and Zavoral, M. and Suchanek, S.},
title = {Participation rate of the target population in colorectal cancer screening – results from the evaluation of the National Colorectal Cancer Screening Program in the Czech Republic},
journal = {Endoscopy},
year = {2024},
volume = {56},
number = {S 02 S 02},
pages = {S476--S477},
doi = {10.1055/s-0044-1783909}
}
EUVIMED